• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Hot Sale Safe Folic Acid--Naturalized Folate Raw Material
Halal Atropa Belladonna Extract Powder10:1
Halal Atractylodis Macrocephalae Rhizoma Extract Powder 10:1
Halal Atractylodes Macrocephala Extract Powder 10:1
Halal Atractylodes Lancea Extract Powder10:1
Halal Astragalus Root Extract Powder10:1

Biocon receives 12 USFDA observations for Malaysia unit

biospectrumasiaJuly 10, 2019

Tag:

Indian biopharmaceutical company Biocon has announced that its Sdn Bhd’s Insulin Glargine Drug Substance, Drug Product and Device assembly facilities in Malaysia underwent a pre-approval inspection by the U.S. FDA between June 24 and July 5, 2019. The inspection across these 3 units concluded with 12 observations issued on the Form 483.

The company will respond to the FDA with a Corrective and Preventive Action Plan and are confident of addressing these observations expeditiously. Biocon does not expect any change to its commercialization plans for Insulin glargine in the U.S. Biocon remains committed to global standards of Quality and Compliance.

Previous:NUS opens new centre for oral health

Next:DTC genetic testing market size to exceed $2.5bn by 2025

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Biocon receives 12 USFDA observations for Malaysia unit | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

Tylosin soluble powder

Tylosin soluble powder
100% Natural Cranberry Extract Proanthocyanidins 50%

100% Natural Cranberry Extract Proanthocyanidins 50%
6-Amino-5-chloro-4-pyrimidinecarboxylic acid

6-Amino-5-chloro-4-pyrimidinecarboxylic acid
Fosaprepitant dimeglumine injection

Fosaprepitant dimeglumine injection
cucurbitacin B

cucurbitacin B
N-(2-Hydroxyethyl)piperazine(1-Piperazineethanol)

N-(2-Hydroxyethyl)piperazine(1-Piperazineethanol)
Ticagrelor

Ticagrelor
Top Quality Gingerol

Top Quality Gingerol
econazole nitrate

econazole nitrate
Olive Leaf Extract

Olive Leaf Extract

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service